13 transactions in one company, from January 8, 2025 to July 25, 2025.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| Verve Therapeutics, Inc. | VERV | 13 | — | $12K |
13 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|---|
| Verve Therapeutics, Inc. | VERV | Joan NickersonChiefDERIV | Jul 25 | DReturned to issuer | 125,000 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Joan NickersonChiefDERIV | Jul 25 | DReturned to issuer | 102,016 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Joan NickersonChiefDERIV | Jul 25 | DReturned to issuer | 6,630 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Joan NickersonChiefDERIV | Jul 25 | DReturned to issuer | 18,000 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Joan NickersonChiefDERIV | Jul 25 | DReturned to issuer | 40,000 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Joan NickersonChiefDERIV | Jul 25 | DReturned to issuer | 225,000 | — | — | 0derivatives |
| Verve Therapeutics, Inc. | VERV | Joan NickersonChief | Jul 25 | UTender offer | 17,420 | — | — | 0 |
| Verve Therapeutics, Inc. | VERV | Joan NickersonChiefDERIV | Apr 1 | MPLANOption exercise | 6,000 | $0.00 | —? | 18,000derivatives |
| Verve Therapeutics, Inc. | VERV | Joan NickersonChiefDERIV | Apr 1 | MPLANOption exercise | 3,315 | $0.00 | —? | 6,630derivatives |
| Verve Therapeutics, Inc. | VERV | Joan NickersonChief | Apr 2 | SPLAN | 2,777 | $4.15 | $12K | 17,420 |
| Verve Therapeutics, Inc. | VERV | Joan NickersonChief | Apr 1 | MPLANOption exercise | 9,315 | — | — | 20,197 |
| Verve Therapeutics, Inc. | VERV | Joan NickersonChiefDERIV | Jan 8 | AAward | 40,000 | $0.00 | —? | 40,000derivatives |
| Verve Therapeutics, Inc. | VERV | Joan NickersonChiefDERIV | Jan 8 | AAward | 225,000 | $0.00 | —? | 225,000derivatives |